Pfizer To Say Whether COVID-19 Vaccine Works After Election

By John Wilkerson / October 27, 2020 at 2:20 PM
Pfizer will likely say whether its coronavirus vaccine works after the election, Pfizer CEO Albert Bourla said Tuesday (Oct. 27), then by the end of November the company hopes to apply for emergency use authorization. Bourla said previously the company might have interim phase 3 clinical trial results by the end of October, and it might, but then company scientists need five to seven days to review the data before releasing top line results. Bourla said he expects the independent...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.